Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. IONS
10. ONON

Go back to Definium Therapeutics to Discuss Topline Results from Phase 3 Panorama Study in Generalized Anxiety Disorder on September 14, 2026
(NASDAQ: DFTX) Delayed: 40.32 +1.04 (2.65%)
Previous Close $39.28    52 Week High $ 
Open $39.42    52 Week Low $ 
Day High $40.39    P/E N/A 
Day Low $38.70    EPS $ 
Volume 1,753,482